Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 3/2019

25.07.2019 | short review

Cutaneous melanoma—The benefit of screening and preventive measures

verfasst von: MD Magdalena Seidl-Philipp, MD Van Anh Nguyen

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

The incidence rates of cutaneous melanoma are continually rising in the Caucasian population with the highest rates in Australia and New Zealand. The genesis of melanoma is a complex interplay between genetic predisposition and exogenous factors. The major known exogenous risk factor of this potentially lethal malignancy is ultraviolet (UV) radiation. In the last decades diverse prevention strategies have been developed which in case of primary prevention are aimed to protect the skin from high-dose UV radiation. Although its effect is only visible after a long period of time and despite the growing awareness in the general population, it seems that primary prevention interventions are often not carried out as recommended. It was proposed that particularly in Europe where incidence rates are still increasing, the development and implementation of primary prevention campaigns should be pursued further. Secondary prevention implies early detection of melanoma by using skin cancer screenings. However, according to recent reviews there is only limited evidence on impact and benefit of routine skin cancer screenings in the adult general population. Thus, it was suggested that future research should focus on effects of targeted screening in population subgroups with increased risk for melanoma.
Literatur
1.
Zurück zum Zitat Garbe C, Blum A. Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol. 2001;14(5):280–90. PubMedCrossRef Garbe C, Blum A. Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol. 2001;14(5):280–90. PubMedCrossRef
2.
Zurück zum Zitat International Agency for Research on Cancer WHO. GLOBOCAN 2018: Estimated age-standardized incidence rates in 2018, melanoma of skin, both sexes, all ages. 2019. http://​globocan.​iarc.​fr. Accessed 29 Jan 2019. International Agency for Research on Cancer WHO. GLOBOCAN 2018: Estimated age-standardized incidence rates in 2018, melanoma of skin, both sexes, all ages. 2019. http://​globocan.​iarc.​fr. Accessed 29 Jan 2019.
3.
Zurück zum Zitat Erdmann F, Lortet-Tieulent J, Schüz J, et al. International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk? Int J Cancer. 2013;132(2):385–400. PubMedCrossRef Erdmann F, Lortet-Tieulent J, Schüz J, et al. International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk? Int J Cancer. 2013;132(2):385–400. PubMedCrossRef
4.
Zurück zum Zitat Jhappan C, Noonan FP, Merlino G. Ultraviolet radiation and cutaneous malignant melanoma. Oncogene. 2003;22(20):3099–112. PubMedCrossRef Jhappan C, Noonan FP, Merlino G. Ultraviolet radiation and cutaneous malignant melanoma. Oncogene. 2003;22(20):3099–112. PubMedCrossRef
5.
Zurück zum Zitat MacKie RM. Incidence, risk factors and prevention of melanoma. Eur J Cancer. 1998;34(Suppl 3):3–6. CrossRef MacKie RM. Incidence, risk factors and prevention of melanoma. Eur J Cancer. 1998;34(Suppl 3):3–6. CrossRef
6.
Zurück zum Zitat Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 2005;41(1):45–60. PubMedCrossRef Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 2005;41(1):45–60. PubMedCrossRef
7.
Zurück zum Zitat Pleasance ED, Cheetham RK, Stephens PJ, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature. 2010;463(7278):191–6. PubMedCrossRef Pleasance ED, Cheetham RK, Stephens PJ, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature. 2010;463(7278):191–6. PubMedCrossRef
8.
Zurück zum Zitat Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med. 1999;340(17):1341–8. PubMedCrossRef Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med. 1999;340(17):1341–8. PubMedCrossRef
9.
Zurück zum Zitat Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control. 2001;12(1):69–82. PubMedCrossRef Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control. 2001;12(1):69–82. PubMedCrossRef
10.
Zurück zum Zitat Ghiasvand R, Rueegg CS, Weiderpass E, Green AC, Lund E, Veierød MB. Indoor tanning and melanoma risk: long-term evidence from a prospective population-based cohort study. Am J Epidemiol. 2017;185(3):147–56. PubMed Ghiasvand R, Rueegg CS, Weiderpass E, Green AC, Lund E, Veierød MB. Indoor tanning and melanoma risk: long-term evidence from a prospective population-based cohort study. Am J Epidemiol. 2017;185(3):147–56. PubMed
11.
Zurück zum Zitat Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer. 2005;41(1):28–44. PubMedCrossRef Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer. 2005;41(1):28–44. PubMedCrossRef
12.
Zurück zum Zitat van der Leest RJ, Flohil SC, Arends LR, de Vries E, Nijsten T. Risk of subsequent cutaneous malignancy in patients with prior melanoma: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2015;29(6):1053–62. PubMedCrossRef van der Leest RJ, Flohil SC, Arends LR, de Vries E, Nijsten T. Risk of subsequent cutaneous malignancy in patients with prior melanoma: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2015;29(6):1053–62. PubMedCrossRef
13.
Zurück zum Zitat Ford D, Bliss JM, Swerdlow AJ, et al. Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE). Int J Cancer. 1995;62(4):377–81. PubMedCrossRef Ford D, Bliss JM, Swerdlow AJ, et al. Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE). Int J Cancer. 1995;62(4):377–81. PubMedCrossRef
14.
Zurück zum Zitat Ransohoff KJ, Jaju PD, Tang JY. Familial skin cancer syndromes: increased melanoma risk. J Am Acad Dermatol. 2016;74(3):423–34. PubMedCrossRef Ransohoff KJ, Jaju PD, Tang JY. Familial skin cancer syndromes: increased melanoma risk. J Am Acad Dermatol. 2016;74(3):423–34. PubMedCrossRef
15.
Zurück zum Zitat Marks R. Campaigning for melanoma prevention: a model for a health education program. J Eur Acad Dermatol Venereol. 2004;18(1):44–7. PubMedCrossRef Marks R. Campaigning for melanoma prevention: a model for a health education program. J Eur Acad Dermatol Venereol. 2004;18(1):44–7. PubMedCrossRef
16.
17.
Zurück zum Zitat Curiel-Lewandrowski C, Chen SC, Swetter SM. Screening and prevention measures for melanoma: is there a survival advantage? Curr Oncol Rep. 2012;14(5):458–67. PubMedPubMedCentralCrossRef Curiel-Lewandrowski C, Chen SC, Swetter SM. Screening and prevention measures for melanoma: is there a survival advantage? Curr Oncol Rep. 2012;14(5):458–67. PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat S3 Leitlinie Prävention von Hautkrebs, Version 1.1, 2014 S3 Leitlinie Prävention von Hautkrebs, Version 1.1, 2014
20.
Zurück zum Zitat Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol. 2011;29(3):257–63. PubMedCrossRef Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol. 2011;29(3):257–63. PubMedCrossRef
21.
Zurück zum Zitat Montague M, Borland R, Sinclair C. Slip! Slop! Slap! and SunSmart, 1980–2000: Skin cancer control and 20 years of population-based campaigning. Health Educ Behav. 2001;28(3):290–305. PubMedCrossRef Montague M, Borland R, Sinclair C. Slip! Slop! Slap! and SunSmart, 1980–2000: Skin cancer control and 20 years of population-based campaigning. Health Educ Behav. 2001;28(3):290–305. PubMedCrossRef
22.
Zurück zum Zitat van der Leest RJ, de Vries E, Bulliard JL, et al. The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010. J Eur Acad Dermatol Venereol. 2011;25(12):1455–65. PubMedCrossRef van der Leest RJ, de Vries E, Bulliard JL, et al. The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010. J Eur Acad Dermatol Venereol. 2011;25(12):1455–65. PubMedCrossRef
24.
Zurück zum Zitat Swindler JE, Lloyd JR, Gil KM. Can sun protection knowledge change behavior in a resistant population? Cutis. 2007;79(6):463–70. PubMed Swindler JE, Lloyd JR, Gil KM. Can sun protection knowledge change behavior in a resistant population? Cutis. 2007;79(6):463–70. PubMed
25.
Zurück zum Zitat Seité S, Del Marmol V, Moyal D, Friedman AJ. Public primary and secondary skin cancer prevention, perceptions and knowledge: an international cross-sectional survey. J Eur Acad Dermatol Venereol. 2017;31(5):815–20. PubMedPubMedCentralCrossRef Seité S, Del Marmol V, Moyal D, Friedman AJ. Public primary and secondary skin cancer prevention, perceptions and knowledge: an international cross-sectional survey. J Eur Acad Dermatol Venereol. 2017;31(5):815–20. PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Falk M, Magnusson H. Sun protection advice mediated by the general practitioner: an effective way to achieve long-term change of behaviour and attitudes related to sun exposure? Scand J Prim Health Care. 2011;29(3):135–43. PubMedPubMedCentralCrossRef Falk M, Magnusson H. Sun protection advice mediated by the general practitioner: an effective way to achieve long-term change of behaviour and attitudes related to sun exposure? Scand J Prim Health Care. 2011;29(3):135–43. PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat McPherson M, Elwood M, English DR, Baade PD, Youl PH, Aitken JF. Presentation and detection of invasive melanoma in a high-risk population. J Am Acad Dermatol. 2006;54(5):783–92. PubMedCrossRef McPherson M, Elwood M, English DR, Baade PD, Youl PH, Aitken JF. Presentation and detection of invasive melanoma in a high-risk population. J Am Acad Dermatol. 2006;54(5):783–92. PubMedCrossRef
28.
Zurück zum Zitat Terushkin V, Halpern AC. Melanoma early detection. Hematol Oncol Clin North Am. 2009;23(3):481–500. PubMedCrossRef Terushkin V, Halpern AC. Melanoma early detection. Hematol Oncol Clin North Am. 2009;23(3):481–500. PubMedCrossRef
29.
Zurück zum Zitat Breitbart EW, Waldmann A, Nolte S, et al. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol. 2012;66(2):201–11. PubMedCrossRef Breitbart EW, Waldmann A, Nolte S, et al. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol. 2012;66(2):201–11. PubMedCrossRef
30.
Zurück zum Zitat Choudhury K, Volkmer B, Greinert R, Christophers E, Breitbart EW. Effectiveness of skin cancer screening programmes. Br J Dermatol. 2012;167(Suppl 2):94–8. PubMedCrossRef Choudhury K, Volkmer B, Greinert R, Christophers E, Breitbart EW. Effectiveness of skin cancer screening programmes. Br J Dermatol. 2012;167(Suppl 2):94–8. PubMedCrossRef
31.
Zurück zum Zitat Brunssen A, Waldmann A, Eisemann N, Katalinic A. Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: a systematic review. J Am Acad Dermatol. 2017;76(1):129–139.e10. PubMedCrossRef Brunssen A, Waldmann A, Eisemann N, Katalinic A. Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: a systematic review. J Am Acad Dermatol. 2017;76(1):129–139.e10. PubMedCrossRef
32.
Zurück zum Zitat US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for skin cancer: US preventive services task force recommendation statement. JAMA. 2016;316(4):429–35. CrossRef US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for skin cancer: US preventive services task force recommendation statement. JAMA. 2016;316(4):429–35. CrossRef
33.
Zurück zum Zitat Katalinic A, Eisemann N, Waldmann A. Skin cancer screening in Germany. Documenting melanoma incidence and mortality from 2008 to 2013. Dtsch Arztebl Int. 2015;112(38):629–34. PubMedPubMedCentral Katalinic A, Eisemann N, Waldmann A. Skin cancer screening in Germany. Documenting melanoma incidence and mortality from 2008 to 2013. Dtsch Arztebl Int. 2015;112(38):629–34. PubMedPubMedCentral
Metadaten
Titel
Cutaneous melanoma—The benefit of screening and preventive measures
verfasst von
MD Magdalena Seidl-Philipp
MD Van Anh Nguyen
Publikationsdatum
25.07.2019
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2019
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-019-0512-7

Weitere Artikel der Ausgabe 3/2019

memo - Magazine of European Medical Oncology 3/2019 Zur Ausgabe